RX Border Defense: FDA’s ‘Green List’ Surrendered GLP-1 Supply to China

RX Border Defense: FDA’s ‘Green List’ Surrendered GLP-1 Supply to China

The U.S. Food and Drug Administration (FDA) has enabled China to corner the market on GLP-1 obesity drugs to the detriment of the safety of Americans, RX Border Defense's Patsy Writesman told Breitbart News Washington Bureau Chief Matthew Boyle on Thursday during an event on the threat of China. The post Exclusive – RX Border Defense’s Patsy Writesman on CCP’s Stranglehold on Skinny: FDA’s ‘Green List’ Surrendered GLP-1 Supply Chain to China app…